GSK466317A

Overview

GSK466317A is a PKA inhibitor, with an IC 50 of 12.59 μM. GSK466317A also inhibits GRK1 , GRK2 , and GRK5 , with IC 50 s of 1000, 31.62, and 39.81 μM, respectively.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > TGF-beta/Smad | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > PKA | Products > Signaling Pathways > G Protein-coupled Receptor Kinase (GRK)

Product Information

• Catalog No.: HY-119232
• CAS No.: 864082-48-4
• Molecular Formula: C21H16ClF3N4O2
• Molecular Weight: 448.83
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source